This page is dedicated to the Invasive Bacterial Infection research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Associate Physician in Pediatrics, Division of Infectious Diseases
Assistant Professor of Pediatrics, Harvard Medical School
The Invasive Bacterial Infection research study was recently established in 2025 and is led by Dr. Kristin Moffitt.